European Parliament to vote on patient information proposal
This article was originally published in Scrip
The European Parliament is due to vote tomorrow on the proposal to give the pharmaceutical industry a role in providing patients with information on prescription medicines. All the signs are that it will pass most of the amendments made by MEPs to focus the proposal on the interests of patients rather than those of the industry, thereby increasing the pressure on ministers within EU nations to reach a common position themselves when they debate it on 6 December.
You may also be interested in...
The EU has published an action plan that is intended to upgrade the bloc’s intellectual property framework while ensuring that goods such as medicines and vaccines are made as widely available as possible. The initiative is part of wide-ranging plans to support member states’ recovery from the pandemic crisis and help ensure the EU’s resilience to future health threats.
Under EU rules, once a medicinal product has been placed on the market in a country of the EEA – the EU plus Iceland, Liechtenstein and Norway
The EU pharmaceutical strategy published on 25 November will be the first step in a “complete overhaul” of the medicines legislative framework to be proposed in about two years’ time, says the European Commission.